Anti-PD-L1 therapy and the onset of diabetes mellitus with positive pancreatic autoantibodies

An 84-year-old woman with metastatic squamous cell carcinoma of the nasopharynx and no history of diabetes was started on the antiprogrammed cell death ligand-1 (anti-PD-L1) antibody durvalumab. Four months later, she presented in diabetic ketoacidosis with glucose 488 mg/dL, anion gap 16, positive...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:BMJ Case Rep
Main Authors: Way, Jennifer, Drakaki, Alexandra, Drexler, Andrew, Freeby, Matthew
Format: Artigo
Sprog:Inglês
Udgivet: BMJ Publishing Group 2017
Fag:
Unexpected Outcome (Positive or Negative) Including Adverse Drug Reactions
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5652350/
https://ncbi.nlm.nih.gov/pubmed/28978581
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2017-220415
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker